MedPath

Prevalence of Ocular Surface Disease in Patients with Glaucoma Using Topical Intraocular Pressure-Lowering Medications at Srinagarind Hospital

Not Applicable
Completed
Conditions
&#45
Ocular surface disease&#45
Glaucoma medication&#45
TBUT&#45
Schirmer test&#45
Lissamine green staining
Glaucoma
Ocular surface disease
Registration Number
TCTR20130923001
Lead Sponsor
Faculty of Medicine, Khon Kaen University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
143
Inclusion Criteria

- Age more than 20 years old
- The subjects must be informed consent
- Diagnosed as primary open angle glaucoma, pseudoexfoliation glaucoma, pigment dispersion glaucoma, ocular hypertension, chronic angle closure glaucoma or juvenile open angle glaucoma
- subjects use IOP lowering agent(s) more than 6 month continuously
- subjects don't have any prior glaucoma surgery

Exclusion Criteria

- subjects who had undergone any surgery which affect tear film
- subjects have eye trauma
- subjects who have any of the disease following
- Autoimmune disorders
. Primary Sjogren syndrome
. Secondary Sjogren syndrome associated with rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis (scleroderma), polymyositis, dermatomyositis, primary biliary cirrhosis
. Graft versus host disease
. Immune reaction after radiation to head and neck
- Infiltrative processes
. Lymphoma
. Amyloidosis
. Hemochromatosis
. Sarcoidosis
. Infectious process
. HIV-diffuse infiltrative lymphadenopathy syndrome
. Trachoma
- Neuropathic dysfunction
. Multiple sclerosis
. Cranial neuropathies (Bell’s palsy, vasculitis)
. Parkinson disease
. Alzheimer disease
- Endocrine dysfunction
. Androgen deficiency
. subject use and drugs that affect tear film
- Antihypertensives : clonidine, propanolol
- Antidepressants : amitriptyline, nortriptyline, fluoxetine
- Benztropine
- Antihistamine : diphenhydramine hydrochloride, loratadine, cetirizine, fexofenadine
- Marijuana
- Thiabendazole
- Diphenoxylate hydrochloride
- subjects who used artificial tear, cyclosporin eye drop, steroids, topical ocular NSAIDs or autologous serum within 3 months
- Subjects who on punctual plug

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ocular surface disease severity TBUT, Schirmer test, lissamine green staining score
Secondary Outcome Measures
NameTimeMethod
Relationship between number of eyedrops and ocular surface disease TBUT, Schirmer test, lissamine green staining score,Relationship between duration of medication and ocular surface disease TBUT, Schirmer test, lissamine green staining score,Relationship between number of types of eyedrop and ocular surface disease TBUT, Schirmer test, lissamine green staining score
© Copyright 2025. All Rights Reserved by MedPath